Trials / Recruiting
RecruitingNCT07042581
A Study of Revaree Plus in People With Breast Cancer
Evaluation of Revaree Plus in Women With Breast Cancer
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.
Conditions
- Breast Cancer
- Stage 0 Breast Cancer
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer
- Stage 0 Breast Carcinoma
- Stage II Breast Carcinoma
- Stage III Breast Carcinoma
- Hormone-receptor-positive Breast Cancer
- Hormone Receptor Positive Breast Carcinoma
- Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Revaree Plus | Revaree Plus is a hyaluronic acid vaginal suppository |
Timeline
- Start date
- 2025-06-20
- Primary completion
- 2029-06-20
- Completion
- 2029-06-20
- First posted
- 2025-06-29
- Last updated
- 2026-02-06
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07042581. Inclusion in this directory is not an endorsement.